Registration
BROWNSTEIN HYATT FARBER SCHRECK, LLP for FERRING PHARMACEUTICALS INC.
Client
Income
—
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
issues related to microbiome, oncology, fertility, and health equity
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM DUNHAM New | Deputy Chief of Staff for Policy, Leader Kevin McCarthy; Policy Director, Leader Kevin McCarthy; Executive Director, Republican Study Committee; Budget Associate, Rep. Tom McClintock |
| EMILY FELDER New | Director of the Office of Legislation, CMS; Counsel, House Energy and Commerce Committee; Counsel, Senate Committee on Homeland Security and Government Affairs; Counsel, House Oversight and Government Reform Committee |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| FERRING HOLDINGS SA | Switzerland | Switzerland | 100.0% | — |
| DR. FREDERIK PAULSEN FOUNDATION | Switzerland | Switzerland | 100.0% | — |
| FERRING BV | Netherlands | Netherlands | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.